This information is intended for US healthcare professionals.

Brought to you by Gilead Oncology logo in white text.


Register here, and Gilead will send monthly updates about the ongoing investigation into higher-risk MDS directly to you.

Please fix errors below.

Terms & Conditions

Gilead respects the privacy of your personal information. Gilead, and companies providing services to Gilead, may use the information that you provide to send you marketing or informational materials about MDS and other updates, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research and health topics that may be of interest to you.

Gilead, and companies providing services to Gilead, will not sell or rent your personally identifiable information. Review our Privacy Policy for more information.

I agree to the Terms and Conditions.*

MDS, myelodysplastic syndrome; NPI, National Provider Identifier.